In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Medtronic acquires Physio-Control from Bain for $538mm in stock swap

Executive Summary

To broaden its critical care product offerings, Medtronic acquired defibrillator makerPhysio-Control from from Bain Capital (which bought it from Lilly in 1994) in a stock transaction, paying $27.50 a share, about a (pr)26% premium.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies